Five patients with panic disorder were placed on low doses of imipramine. All patients had shown dramatic improvement after three weeks of treatment, when plasma levels of imipramine and desipramine were measured. Plasma levels corresponded to the low doses being administered. This result implies that the mechanism of action of tricyclic antidepressants is different in patients with panic disorder than in patients with depressive disorder.
Get full access to this article
View all access options for this article.
References
1.
KleinD. K.ZitrinC. M., and WoernerM. G., Imipramine and Phobia, Psychopharmacology Bulletin, 13, pp. 24–27, 1977.
2.
KellyD.GuirgvisW.FrommerE.Mitchell-HeggsN., and SargantW., Treatment of Phobic States with Antidepressants, British Journal of Psychiatry, 116, pp. 387–398, 1970.
3.
SheehanD. V., The Efficient Treatment of Phobic Disorders, in Psychiatric Medicine Update, MarschreckT. C. (ed.), Elsevier, New York, pp. 189–204, 1979.
4.
SweeneyD. R.GoldM. S.PottashA. L. C., and DaviesR. K., Neurobiological Theories, in Handbook on Stress and Anxiety, KutaskI. L. and SchlesingerL. B. (eds.), Jossey-Bass, San Francisco, pp. 112–122, 1980.
5.
MartinD. M.PottashA. L. C., and GoldM. S.RapidA., Sensitive Method for the Separation and Measurement of Tricyclic Antidepressants and Their Psychoactive Metabolites by High-Pressure Liquid Chromatography, Neuroscience Abstracts S, 409, 1979.